C&R Research Inc. (KOSDAQ:359090)

South Korea flag South Korea · Delayed Price · Currency is KRW
1,899.00
-22.00 (-1.15%)
At close: Jul 21, 2026
Market Cap21.83B -62.6%
Revenue (ttm)62.70B +1.1%
Net Income2.41B -31.8%
EPS203.54 -36.6%
Shares Out 11.49M
PE Ratio9.33
Forward PEn/a
Dividend50.00 (2.60%)
Ex-Dividend DateDec 29, 2025
Volume9,107
Open1,902.00
Previous Close1,921.00
Day's Range1,870.00 - 1,920.00
52-Week Range494.00 - 2,595.00
Beta-0.01
Analystsn/a
Price Targetn/a
Earnings DateAug 14, 2026

About C&R Research

C&R Research Inc. engages in the of clinical development for pharmaceuticals and medical devices. The company’s therapeutic area comprises oncology, cardiovascular, endocrinology, dermatology, central nervous system, ophthalmology, and rare disease.The company was founded in 1997 and is based in Seoul, South Korea. [Read more]

Industry Commercial Physical and Biological Research
Founded 1997
Employees 510
Stock Exchange KOSDAQ
Ticker Symbol 359090
Full Company Profile

Financial Performance

In 2025, C&R Research's revenue was 64.98 billion, an increase of 8.87% compared to the previous year's 59.69 billion. Earnings were 2.59 billion, a decrease of -32.64%.

Financial Statements